www.mediafax.ro/sanatate/pet-ct-psma-o-investigati

In prostate cancer, assessing disease extent is crucial for treatment planning. PET-CT PSMA is a nuclear medicine investigation used for staging and restaging, providing essential information for personalized treatment strategies. This method is available at SANADOR Oncology Center in Romania, where it was introduced nationally. PSMA, a protein found in prostate tissue, is targeted for molecular imaging. The examination involves intravenous administration of a gallium-68 radiotracer, highlighting areas expressing PSMA. PET-CT PSMA aids in identifying lymphatic, bone, or visceral lesions, enhancing clinical evaluation. It is also significant for restaging after prostatectomy, especially when PSA levels rise, indicating potential biochemical recurrence. The results are interpreted alongside PSA values and other clinical data, with indications set individually by the physician. Patients at SANADOR can access this advanced examination without traveling abroad, benefiting from a…